Biocidal Products Regulation
CS Regulatory Ltd are currently advising several clients on their requirements under new legislation. We have detailed experience of the process, and understand the requirements of the European Chemicals Agency (ECHA) and Evaluating member state Competent Authorities (ECAs) to enable successful registration.
The Biocidal Product Regulation (BPR), Regulation (EU) 528/2012, on the use and placing on the market of biocidal products was published on 27 June 2012.
The objective of the new Regulation is to improve the functioning of the internal market in biocidal products whilst ensuring a high level of environmental and human health protection. For example, biocidal actives and products are unlikely to receive authorisation for some uses if classified as Cat 1 CMRs, Cat 1, 2 or 3 acute toxicants, PBT/ vPvB, endocrine disruption, neurotoxic or immunotoxic.
Authorisation may be granted, however, for products with these effects dependent upon socio-economic analysis or strict risk mitigation. Active and products possessing these properties will, however, be subject to consideration for replacement.
CS Regulatory Ltd are currently advising several clients on their requirements under this new legislation. We have detailed experience of the process, and understand the requirements of the European Chemicals Agency (ECHA) and Evaluating member state Competent Authorities (ECAs) to enable successful registration.
CS Regulatory Ltd has numerous Information Sheets available for use by our Clients and Colleagues.
